1. Effect of age on outcomes after allogeneic disc tissue supplementation in patients with chronic discogenic low back pain in the VAST trial.
- Author
-
Hunter CW, Guyer R, Froimson M, and DePalma MJ
- Subjects
- Adult, Age Factors, Female, Humans, Male, Pain Measurement, Transplantation, Homologous, Treatment Outcome, Chronic Pain etiology, Chronic Pain surgery, Intervertebral Disc transplantation, Intervertebral Disc Degeneration complications, Intervertebral Disc Degeneration surgery, Low Back Pain etiology, Low Back Pain surgery
- Abstract
Aim: To explore the effects of viable allogeneic disc tissue supplementation in younger patients with discogenic chronic low back pain (CLBP). Patients & methods: VAST was a randomized placebo-controlled trial of disc allograft supplementation in 218 patients with discogenic CLBP. We conducted a post hoc analysis of change from baseline to 12 months in Oswestry Disability Index (ODI) and visual analog scale for pain intensity scores stratified by patient age. Results: Patients aged <42 years receiving allograft experienced greater improvement in ODI (p = 0.042) and a higher ODI response rate (≥10-, ≥15- and ≥20-point reductions in ODI) than those receiving saline (p = 0.001, p = 0.002 and p = 0.021, respectively). Conclusion: Young patients with discogenic CLBP may have significant functional improvement following nonsurgical disc allograft supplementation.
- Published
- 2022
- Full Text
- View/download PDF